PHARMA NORD EXPORT ApS: Financial statements 2018
CVR: 70996510
Source: annual report 2018, Danish Business Authority
01/01/2018 – 31/12/2018
PHARMA NORD EXPORT ApS (CVR 70996510) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK 2,076,384 and a net result of DKK 4,272,843 compared with DKK 3,460,551 the year before. That is an increase of 6.7% compared with the year before. Equity in the 2018 report amounted to DKK 69,779,023. The solvency ratio was 82.7%.
- Gross Profit
- DKK 2,076,384
- Profit/Loss
- DKK 4,272,843
- Equity
- DKK 69,779,023
- Total Assets
- DKK 84,388,378
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | - | 2.1 mio. | 4.3 mio. | 69.8 mio. | - |
| 2017 | - | 1.9 mio. | 3.5 mio. | 65.5 mio. | - |
| 2016 | - | 2.2 mio. | 2.7 mio. | 62 mio. | - |
| 2015 | - | 2.3 mio. | 3.2 mio. | 59.3 mio. | - |
| 2014 | - | 1.9 mio. | 3.1 mio. | 56.1 mio. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
As of October 12, 2018, PHARMCO II ApS is registered as an owner of PHARMA NORD EXPORT ApS with an ownership share of 50%.
PHARMA NORD EXPORT ApS has published its annual report for 2017. Gross profit came to DKK 1,945,707, and the net result was DKK 3,460,551.
About PHARMA NORD EXPORT ApS
PHARMA NORD EXPORT ApS is a Danish company of the type Anpartsselskab based in Vejle, founded in 1982. The company is registered under the industry Engroshandel med andre fødevarer. The management consists of Eli Wallin. The board consists of Michael Christiani Havemann (chair) and Eli Wallin. The company is owned by PHARMCO II ApS and PharmCo III ApS. According to the 2025 annual report, the company had an average of 66 employees. In 2025, the company reported a gross profit of DKK 1,575,000 and a net result of DKK 11,516,000 compared with DKK 6,889,205 the year before. Equity in the 2025 report amounted to DKK 46,928,000.